Boardroom Alpha
10-K primary document
AVNS · Annual Report (Form 10-K) · Filed February 24, 2026

Avanos Medical Inc10-K exhibit

avns2025form10kex21.htm
Document

Exhibit No. 21
Avanos Medical, Inc.

Subsidiaries
CompanyJurisdiction of Incorporation or Organization
Avanos Medical (Shanghai) Co., Ltd.China
Avanos Medical (Thailand) LimitedThailand
Avanos Medical Australia Pty Ltd.Australia
Avanos Medical Belgium BVBABelgium
Avanos Medical Brasil Consultoria Ltda.Brazil
Avanos Medical Brasilia, LLCDelaware
Avanos Medical Canada Inc.Canada
Avanos Medical Deutschland GmbHGermany
Avanos Medical France SASFrance
Avanos Medical India Private LimitedIndia
Avanos Medical International, Inc.Delaware
Avanos Medical Japan, Inc.Delaware
Avanos Medical Japan, Inc. (Japanese Branch)Japan
Avanos Medical Mexico, S. de R.L. de C.V.Mexico
Avanos Medical Nederland B.V.Netherlands
Avanos Medical Sales, LLCNorth Carolina
Avanos Medical Sao Paulo, LLCDelaware
Avanos Medical Singapore Pte. Ltd.Singapore
Avanos Medical South Africa (Pty) Ltd.South Africa
Avanos Medical UK LimitedUnited Kingdom
Avent Holdings, LLCDelaware
Avent S. de R.L. de C.V.Mexico
Avent, Inc.Delaware
Diros Technology Inc.Canada
I-Flow Holdings, LLCDelaware
Microcuff GmbHGermany
Avent Investment, LLCDelaware
Avanos Medical Sverige ABSweden
Nexus Medical, LLCKansas
Avanos Medical Portugal Lda.Portugal

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer